Characterization of ethylcellulose: Starch-based film coatings for colon targeting

Drug Development and Industrial Pharmacy

Volumn 35, Issue 10, 2009, Pages 1190-1200

  Karrout, Youness ^a   Neut, Christel ^a   Wils, Daniel ^b   Siepmann, Florence ^a   Deremaux, Laetitia ^b   Desreumaux, Pierre ^a   Siepmann, Juergen ^a  

^a UNIV LILLE   (France)

^b Roquette Biology and Nutrition Department   (France)

Author keywords

Colon targeting; Controlled release; Ethylcellulose; Film coating; Starch

Indexed keywords

ETHYL CELLULOSE; STARCH;

ACETYLATION; ARTICLE; DRUG DELIVERY SYSTEM; DRY MASS; FILM COATING; POLYMERIZATION; WATER TRANSPORT;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; COLON; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; STARCH; WATER;

EID: 70350683767     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902858868     Document Type: Article

References (22)

1. Meissner Y, Lamprecht A. (2008). Alternative drug delivery approaches for the therapy of inflammatory bowel disease. J Pharm Sci, 97:2878-2891
2. Bondesen S. (1997). Intestinal fate of 5-aminosalicylic acid: Regional and systemic kinetic studies in relation to inflammatory bowel disease. Pharmacol Toxicol, 81(Suppl 2):1-28.
3. Haupt S, Rubinstein A. (2002). The colon as a possible target for orally administered peptides and proteins. Crit Rev Ther Drug Carrier Syst, 19:499-545.
4. Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm, 235:1-15.
5. Semde R, Moës AJ, Devleeschouwer MJ, Amighi K. (2003). Synthesis and enzymatic degradation of epichlorohydrin crosslinked pectins. Drug Dev Ind Pharm, 29:203-213
6. Onishi H, Oosegi T, Machida Y, McGinity JW. (2005). Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: Comparison of simple and conjugate microspheres. Drug Dev Ind Pharm, 31:597-605.
7. Cummings JH, Milojevic S, Harding M, Coward WA, Gibson GR, Botham RL, et al. (1996). In vivo studies of amylose-and ethylcellulose-coated [13C] glucose microspheres as a model for drug delivery to the colon. J Control Release, 40:123-131
8. Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, et al. (1996). Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J Control Release, 38:75-84. (Pubitemid 26027181)
9. Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, et al. (1996). Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J Control Release, 38:85-94. (Pubitemid 26027182)
10. Gazzaniga A, Iamartino P, Maffione G, Sangalli ME. (1994). Oral delayed-release system for colonic specific delivery. Int J Pharm, 108:77-83.
11. Gazzaniga A, Sangalli ME, Giordano F. (1994). Oral Chronotropic drug delivery systems: Achievement of time and/or site specificity. Eur J Pharm Biopharm, 40:246-250 (Pubitemid 24276317)
12. Gazzaniga A, Maroni A, Sangalli ME, Zema L. (2006). Timecontrolled oral delivery systems for colon targeting. Expert Opin Drug Deliv, 3:583-597
13. Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. (2001). In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release, 73:103-110
14. Siccardi D, Turner JR, Mrsny J. (2005). Regulation of intestinal epithelial function: A link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv Drug Deliv Rev, 57:219-235
15. El Yamani J, Mizon C, Capon C, Colombel JF, Fournet B, Cortot A, et al. (1992). Decreased fecal exoglycosidase activities identify a subset of patients with active Crohn's Disease. Clin Sci, 83:409-415
16. Carrette O, Favier C, Mizon C, Neut C, Cortot A, Colombel JF, et al. (1995). Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's Diseases. Dig Dis Sci, 40:2641-2646
17. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. (1997). Fecal b-D-galactosidase production and bifidobacteria are decreased in Crohn's disease. Dig Dis Sci, 42:817-822
18. Friend DR. (2005). New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev, 57:247-265
19. Karrout Y, Neut C, Wils D, Siepmann F, Deremaux L, Dubreuil L, et al. (2009). Colon targeting with bacteria-sensitive films adapted to the disease state, submitted.
20. McConnell EL, Tutas J, Mohamed MAM, Banning D, Basit AW. (2007). Colonic drug delivery using amylose films: The role of aqueous ethylcellulose dispersions in controlling drug release. Cellulose, 14:25-34.
21. Wesseling M, Bodmeier R. (1999). Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, Aquacoat® , or an organic ethylcellulose solution. Eur J Pharm Biopharm, 47:33-38
22. Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. (2005). Blends of aqueous polymer dispersions used for pellet coating: Importance of the particle size. J Control Release, 105:226-239